Expedia shares rise 5.8% as investors lean into its 2026 outlook and margin narrative

Expedia Group (EXPE) is up 5.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks most consistent with investors revisiting Expedia’s recent 2026 guidance and shareholder-return signals, alongside a generally improving tone from Wall Street on travel demand and Expedia’s B2B momentum. No single, company-specific headline appears to fully explain the entire jump, so part of the gain could be catch-up buying after prior volatility in online travel names.

Details:

Expedia’s February 12, 2026 earnings materials outlined full-year 2026 targets that implied mid-to-high single-digit growth and modest EBITDA margin expansion, reinforcing a “growth plus margin” setup for the year.

The same release also disclosed a $0.48 quarterly dividend payable March 26, 2026, which can support sentiment as investors rotate toward cash-return stories.

Recent sell-side commentary has skewed more constructive; for example, a late-January note highlighted improving travel demand conditions and reiterated a bullish stance with a higher price target.

Expedia’s partner-facing updates have emphasized continued double-digit growth in its B2B platform coming out of Q4 2025, which may be helping the market re-rate the quality of earnings.

Sources:

Expedia Group Investor Relations, Investing.com, Expedia Group Partner Blog

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$EXPE Insider Trading Activity

$EXPE insiders have traded $EXPE stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $EXPE stock by insiders over the last 6 months:

CRAIG A JACOBSON sold 3,000 shares for an estimated $814,650
LANCE A SOLIDAY (SVP & Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,705 shares for an estimated $430,552.
MADHUMITA MOINA BANERJEE sold 1,000 shares for an estimated $258,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$EXPE Hedge Fund Activity

We have seen 591 institutional investors add shares of $EXPE stock to their portfolio, and 506 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,974,355 shares (-76.1%) from their portfolio in Q4 2025, for an estimated $559,354,515
WINDACRE PARTNERSHIP LLC removed 1,330,000 shares (-36.1%) from their portfolio in Q4 2025, for an estimated $376,802,300
GOLDMAN SACHS GROUP INC added 1,236,623 shares (+141.8%) to their portfolio in Q4 2025, for an estimated $350,347,662
WELLINGTON MANAGEMENT GROUP LLP removed 1,225,826 shares (-67.8%) from their portfolio in Q4 2025, for an estimated $347,288,764
PACER ADVISORS, INC. removed 1,002,931 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $284,140,381
FMR LLC added 908,192 shares (+242.0%) to their portfolio in Q4 2025, for an estimated $257,299,875
NORGES BANK removed 893,219 shares (-22.7%) from their portfolio in Q4 2025, for an estimated $253,057,874

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$EXPE Analyst Ratings

Wall Street analysts have issued reports on $EXPE in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BTIG issued a "Buy" rating on 02/13/2026
B of A Securities issued a "Buy" rating on 12/19/2025
Argus Research issued a "Buy" rating on 11/10/2025
Evercore ISI Group issued a "Outperform" rating on 11/07/2025
Goldman Sachs issued a "Buy" rating on 11/07/2025
Benchmark issued a "Buy" rating on 11/07/2025

To track analyst ratings and price targets for $EXPE, check out Quiver Quantitative's $EXPE forecast page.

$EXPE Price Targets

Multiple analysts have issued price targets for $EXPE recently. We have seen 24 analysts offer price targets for $EXPE in the last 6 months, with a median target of $267.5.

Here are some recent targets:

Jake Fuller from BTIG set a target price of $330.0 on 03/16/2026
Lloyd Walmsley from Mizuho set a target price of $245.0 on 03/03/2026
Brian Pitz from BMO Capital set a target price of $255.0 on 02/17/2026
Scott Devitt from Wedbush set a target price of $260.0 on 02/17/2026
Thomas Champion from Piper Sandler set a target price of $225.0 on 02/13/2026
Daniel L. Kurnos from Benchmark set a target price of $290.0 on 02/13/2026
Tom White from DA Davidson set a target price of $260.0 on 02/13/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.